VAUGHN JAMES J (Chief Commercial Officer) sold 21.5% of their position (4.50K shares) of GENOMIC HEALTH INC on the open market
Open‑market sale worth $304.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/9/2019ACC: 0001209191-19-052836
Officer· Chief Commercial Officer
Since Oct 2018
-4.50K
Net shares
Net seller
$304.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.50K acquired · 9K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.50K
Price / share
$33.21
Trade value
$149.44K
% of position
27.4%
10/8/2019
16.42K→20.92K
Common Stock
Direct
Shares
−4.50K
Price / share
$67.75
Trade value
$304.88K
% of position
21.5%
10/8/2019
20.92K→16.42K
Total
Net shares
+0.00
Net value
-$155.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/8/2019 | M · Option Exercise | +4.50K | $33.21 | $149.44K | 27.4% | 16.42K | 20.92K |
| Common Stock Direct | 10/8/2019 | S · Sale | −4.50K | $67.75 | $304.88K | 21.5% | 20.92K | 16.42K |
| Total | +0.00 | -$155.43K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy) Holding
Direct
Converts to
Common Stock
4.50K shares
Shares
−4.50K
Strike price
33.21
Held after
39.71K
Exercisable
—
10/8/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Holding Direct | Common Stock4.50K shares | 10/8/2019 | M · Option Exercise | −4.50K | 33.21 | — | 39.71K |